Gluskin Sheff & Assoc Inc Becton Dickinson & CO Transaction History

Gluskin Sheff & Assoc Inc

  • $814 Million
  • Q3 2024

A detailed history of Gluskin Sheff & Assoc Inc transactions in Becton Dickinson & CO stock. As of the latest transaction made, Gluskin Sheff & Assoc Inc holds 25,303 shares of BDX stock, worth $5.76 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares
25,303
Previous 20,582 22.94%
Holding current value
$5.76 Million
Previous $4.81 Million 26.82%
% of portfolio
0.75%
Previous 0.58%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$221.47 - $242.41 $1.05 Million - $1.14 Million
4,721 Added 22.94%
25,303 $6.1 Million
Q2 2024

Aug 14, 2024
BUY
$225.07 - $246.17 $625,919 - $684,598
2,781 Added 15.62%
20,582 $4.81 Million
Q1 2024

May 15, 2024
BUY
$233.45 - $247.73 $310,955 - $329,976
1,332 Added 8.09%
17,801 $4.4 Million
Q4 2023

Feb 14, 2024
SELL
$232.24 - $267.23 $1.16 Million - $1.34 Million
-5,011 Reduced 23.33%
16,469 $4.02 Million
Q3 2023

Nov 14, 2023
SELL
$254.9 - $283.59 $223,802 - $248,992
-878 Reduced 3.93%
21,480 $5.55 Million
Q2 2023

Aug 14, 2023
SELL
$238.39 - $265.32 $933,296 - $1.04 Million
-3,915 Reduced 14.9%
22,358 $5.9 Million
Q1 2023

May 15, 2023
SELL
$229.71 - $259.35 $412,099 - $465,273
-1,794 Reduced 6.39%
26,273 $6.5 Million
Q4 2022

Feb 14, 2023
BUY
$218.29 - $256.91 $96,920 - $114,068
444 Added 1.61%
28,067 $7.14 Million
Q3 2022

Nov 14, 2022
BUY
$51.03 - $264.23 $90,680 - $469,536
1,777 Added 6.88%
27,623 $6.16 Million
Q2 2022

Aug 15, 2022
SELL
$234.74 - $275.42 $79,811 - $93,642
-340 Reduced 1.3%
25,846 $6.37 Million
Q1 2022

May 16, 2022
SELL
$243.64 - $270.48 $45,317 - $50,309
-186 Reduced 0.71%
26,186 $6.97 Million
Q4 2021

Feb 14, 2022
BUY
$230.08 - $250.94 $47,396 - $51,693
206 Added 0.79%
26,372 $6.63 Million
Q3 2021

Nov 12, 2021
BUY
$232.72 - $256.47 $100,302 - $110,538
431 Added 1.67%
26,166 $6.43 Million
Q2 2021

Aug 13, 2021
BUY
$232.65 - $254.58 $868,482 - $950,347
3,733 Added 16.97%
25,735 $6.26 Million
Q1 2021

May 14, 2021
SELL
$232.09 - $256.88 $2,320 - $2,568
-10 Reduced 0.05%
22,002 $5.35 Million
Q4 2020

Feb 16, 2021
SELL
$221.92 - $245.94 $55,036 - $60,993
-248 Reduced 1.11%
22,012 $5.51 Million
Q3 2020

Nov 12, 2020
SELL
$215.77 - $276.76 $112,847 - $144,745
-523 Reduced 2.3%
22,260 $5.18 Million
Q2 2020

Aug 11, 2020
SELL
$219.9 - $263.41 $187,574 - $224,688
-853 Reduced 3.61%
22,783 $5.45 Million
Q1 2020

May 13, 2020
BUY
$195.69 - $279.01 $57,141 - $81,470
292 Added 1.25%
23,636 $5.43 Million
Q4 2019

Feb 12, 2020
SELL
$236.45 - $266.82 $37,122 - $41,890
-157 Reduced 0.67%
23,344 $6.22 Million
Q3 2019

Nov 08, 2019
BUY
$230.58 - $256.08 $5.42 Million - $6.02 Million
23,501 New
23,501 $5.95 Million

Others Institutions Holding BDX

# of Institutions
1,738
Shares Held
249M
Call Options Held
690K
Put Options Held
787K
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Gluskin Sheff & Assoc Inc Portfolio

Follow Gluskin Sheff & Assoc Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gluskin Sheff & Assoc Inc, based on Form 13F filings with the SEC.

News

Stay updated on Gluskin Sheff & Assoc Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email